US FDA considering lowering recommended age for Pfizer/BioNTech Covid-19 boosters

Published
0

A top US Food and Drug Administration official has said that the agency is considering lowering the recommended age for who should receive booster shots of the Pfizer/BioNTech Covid-19 vaccine to as young as 40 years old, based on data from Israel suggesting the vaccine's efficacy is waning.

Israeli scientists presented “data that seemed compelling in the 40 and up age range,” DrPeter Marks, Director of the FDA's Center for Biologics Evaluation and Research said, speaking to the agency's Vaccines and Related Biological Products Advisory Committee.

Opinion

Editorial

Risks ahead
Updated 02 Oct, 2026

Risks ahead

To think that the government would rather push out an elected government than grant a single prisoner some facilities does not square up rationally.
Exit from Iraq
02 Oct, 2026

Exit from Iraq

AMERICAN and British troops have once again shipped out of Iraq. On Wednesday, the foreign forces left the Arab...
Lahore’s ozone warning
02 Oct, 2026

Lahore’s ozone warning

LAHORE has received another warning that its air pollution crisis cannot be treated as a problem that begins with...
Fixing bond markets
Updated 01 Oct, 2026

Fixing bond markets

Pension funds, insurance companies, mutual funds, retail investors, and eventually, foreign investors must become bigger participants in the market.
Call centre rackets
01 Oct, 2026

Call centre rackets

A NUMBER of recent raids conducted by the authorities in different cities point to the growing threat fraudulent ...
Homeward bound
01 Oct, 2026

Homeward bound

FIVE months after Somali pirates captured an oil tanker carrying a 19-member multinational crew, Somali maritime...